Revilab Peptide ML 02 — for hematopoietic system, chemoradioprotector

Revilab ML 02 is an innovative supplement designed to restore the hematopoietic system, normalize blood circulation, and strengthen the immune system. It restores the body’s reserve capacity, has a rejuvenating effect, and reduces the risk of cancer.

Revilab ML 02 consists of a complex of ultra-short bio-regulators—peptides from the T- and B-cell components of the immune system, bone marrow, and liver. The formulation is supplemented with vitamins and omega-3 polyunsaturated fatty acids, which enhance and complement the action of the peptide bio-regulators.

It is not a medication and is used in conjunction with primary treatment.
 

Indications:

• Prevention of vascular diseases, weakened immunity, and hematopoietic disorders;

• Low hemoglobin levels in the blood;

• Impaired hematopoietic function;

• Varicose veins;

• Tendency toward thrombosis;

• Atherosclerosis;

• Angiopathies;

• trophic ulcers;

• frequent and prolonged colds complicated by infections;

• recovery from serious illnesses, injuries, and surgeries;

• stress and physical overexertion;

• metabolic disorders;

• support during chemotherapy and radiation therapy;

• prevention and comprehensive treatment of oncological diseases.